Efficacy of Dhanwantara taila 101 avartita capsules intervention in Dyspareunia
Phase 3
- Conditions
- Health Condition 1: N941- Dyspareunia
- Registration Number
- CTRI/2024/05/067163
- Lead Sponsor
- Dr Pratibha Walikar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Women of sexually active age group between 20-50 years of age.
2.Subjects complaining of pain during or after sexual intercourse.
3.Subjects having pain in 80 percent of sexual encounters with sexual frequency of at least 2/week.
Exclusion Criteria
1.Past sexual assault history
2.Imperforate hymen
3.Anatomical narrow introitus or vaginal shortening
4.Pregnancy and Lactation
5.Known cases of Endometriosis, STD, Benign & Malignant conditions, IBS, Cystitis, Pelvic adhesions, Multiple sclerosis, Fibroids, uncontrolled DM and HTN.
6.Subjects who are on medications like birth control hormonal pills & Anti-depressant drugs.
7.Subjects with fixed retroverted uterus.
8.Vaginismus.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The Primary outcome will be Dhanwantara taila 101 Avartita capsules may help in relieving the symptoms of Dyspareunia.Timepoint: Subjective parameters will be assessed on 0th day,8th day,15th day,30th day and 60th day.
- Secondary Outcome Measures
Name Time Method To improve the quality of life in dyspareuniaTimepoint: Subjective parameters will be assessed on 0th day,8th day,15th day,30th day and 60th day.